Arthrocel (RejuvaJoint) VSL ããã³åºååæ
ãããªã¯èšç®ãããç·è¿«æã®ãã声ã§å§ãŸããŸãïŒãçŸä»£å»åŠãé¢ç¯çãšé¢ç¯çã«ã€ããŠç¥ã£ãŠãããšæã£ãŠããããšã¯ãä»ãæ·±å»ãªçåã«ãããããŠããŸããã30ç§ä»¥å ã«ãã¹ã¿ã³ãã©ãŒã倧åŠãåŒãåãã«åºããããªãºå士ãèšåãããããŒãµã»ã¹ãã¥ã¯ãŒããåæå¯žåã®æ£è ãšããŠç޹ä»ãããèŠèŽè ã¯ãæ¢åã®ããããæ²»çæ³ãã9å广çãªããã·ã³ãã«ãªæäœãã¬ã·ãããçŽæãããŠããŸãâŠ
Restricted Access
+2,000 VSLs & Ads Scaling Now
+50â100 Fresh Daily · 34+ Niches · Personalized S.P.Y. · $29.90/mo
ã¯ããã«
ãããªã¯èšç®ãããç·è¿«æã®ãã声ã§å§ãŸããŸãïŒãçŸä»£å»åŠãé¢ç¯çãšé¢ç¯çã«ã€ããŠç¥ã£ãŠãããšæã£ãŠããããšã¯ãä»ãæ·±å»ãªçåã«ãããããŠããŸããã30ç§ä»¥å ã«ãã¹ã¿ã³ãã©ãŒã倧åŠãåŒãåãã«åºããããªãºå士ãèšåãããããŒãµã»ã¹ãã¥ã¯ãŒããåæå¯žåã®æ£è ãšããŠç޹ä»ãããèŠèŽè ã¯ãæ¢åã®ããããæ²»çæ³ãã9å广çãªããã·ã³ãã«ãªæäœãã¬ã·ãããçŽæãããŠããŸããããã¯æ®éã®ãµããªã¡ã³ãåºåã§ã¯ãããŸãããå®å šã«èšèšããã説åŸã·ã¹ãã ã§ããå®éã®æ©é¢ãå®åšã®èå人ãå®åšã®ææã®ä¿¡é Œæ§ãåããŠãArthrocelãšãã補åã販売ãããã®ã補ååãšããŠRejuvaJointã§è²©å£²ãããŠãããVSLãããã·ã¥ããã¡ãœããããšåŒã¶ãã®ãäžå¿ã«æ§ç¯ãããŠããŸãã
ãã®ãããªã«åºããããèªè ããŸã㯠YouTube ã Facebook ã§å®è¡ãããŠããåºåããªãšãŒã·ã§ã³ãèŠãèªè ã«ãšã£ãŠããã®äœéšã¯æ¬åœã«æ··ä¹±ãããããšãã§ããŸããå¶äœã¯ãã¬ããã¥ãŒã¹ã»ã°ã¡ã³ãã®ãªãºã ãæš¡å£ããŠããŸãããªãºå士ã¯å ¬éä¿å¥å£°æã®æš©åšã®ãããªãºã ã§è©±ããŸããããŒãµã»ã¹ãã¥ã¯ãŒãã¯ãããã¥ã¡ã³ã¿ãªãŒã«çµã¿èŸŒãŸãããããªææ çãªç¬çœãè¡ããŸããèšåºçµ±èšã¯æ»èªæžã¿è«æã®èŠæšã®å ·äœæ§ã§åŒçšãããŸãããããŠçµããã®ã«ãŠã³ãããŠã³ã¿ã€ããŒã¯ã©ã€ããªãŒã¯ã·ã§ã³ã®å èçãªãã¬ãã·ã£ãŒãçã¿åºããŸãããã¹ãŠã®èŠçŽ ãæå³çã«éžã°ããŠãããåèŠçŽ ãéžã°ããçç±ãçè§£ããããšããã®åæã®äžå¿çãªèª²é¡ã§ãã
VSLã¯Arthrocel / RejuvaJointããé¢ç¯çãå®å šã«æé€ãã身äœã®ã³ã©ãŒã²ã³ã¬ãã«ãå埩ãããããšã§é¢ç¯çãé転ãããããã«èšèšããã6ã¶æã®çµå£ãµããªã¡ã³ãçæ³ãšããŠæšå¥šããŠããŸããççã§ã¯ãªããè»éªšæ©èã§ã¯ãªããå 霢ã§ã¯ãªããã³ã©ãŒã²ã³äžè¶³ããã¹ãŠã®é¢ç¯çŸæ£ã®å¯äžã®æ ¹æ¬åå ãšããŠç¹å®ãã2ã€ã®å€©ç¶æåïŒãã·ã¥ããæ ¹æœåºç©ãšè¥¿æŽãªãã®ãªãœãŠç²æ«ãæ£ç¢ºãªå²åã§çµã¿åããããã®ïŒãããã¡ãŒãžãåããé¢ç¯ã®åšãã«æ°žä¹ çãªä¿è·èã圢æããã®ã«ååãªã³ã©ãŒã²ã³åçãåŒãèµ·ããå¯èœæ§ããããšäž»åŒµããŠããŸãããããã¯äžŠå€ãã䞻匵ã§ããã䞊å€ããä¿¡é Œãæã£ãŠãªãããŠããŸãããã®èšäºã調æ»ããåé¡ã¯ãåçŽã«ãããã®äž»åŒµãçå®ã§ãããã©ããã§ã¯ãªããããã¯éèŠã§ãããã©ã®ä¿®èŸçã¢ãŒããã¯ãã£ãããããä¿¡ããããã®ããæå³ãããè³Œå ¥è ã¯èª°ãããããŠæ éãªèªè ãè³Œå ¥æ±ºå®ãããåã«äœãåãå»ãã¹ããã§ãã
Arthrocel (RejuvaJoint) ãšã¯äœãïŒ
Arthrocelã¯è£œååRejuvaJointã§è²©å£²ãããŠãããäž»ã«50æ³ä»¥äžã®æ ¢æ§é¢ç¯çãå€åœ¢æ§é¢ç¯çããŸãã¯é¢é£ããç¶æ ã§èŠããç±³åœäººã«è²©å£²ãããçµå£é£çè£å©é£åã§ãã補åã¯åŸæ¥ã®é¢ç¯ç管çã®å®å šã§æ°žç¶çãªä»£æ¿åãšããŠäœçœ®ä»ããããŠãããNSAIDsãã³ã«ãã³ã¹ããã€ããç©ççæ³ãããã³é¢ç¯çœ®ææè¡ãå«ã¿ãŸããå ¬åŒãŠã§ããµã€ãïŒAmazonãeBayããŸãã¯å°å£²è¬å±ãéããŠã§ã¯ãªãã詳现ã¯VSLãç¹°ãè¿ã匷調ããŠããŸãïŒã§ã®ã¿è²©å£²ããã6ã¶æã®æ²»çãããã³ã«ãäžå¿ã«æ§é åãããè€æ°ããã«ããã±ãŒãžã§æäŸãããŸãã
ãã©ãŒãããã¯VSLã14ã®å€©ç¶æåãšèª¬æãããã®ãçµã¿åãããã«ãã»ã«ããŒã¹ã®ãµããªã¡ã³ãã§ãããååã§èå¥ãããã®ã¯2ã€ã ãã§ãïŒãã·ã¥ããæ ¹æœåºç©ãšããã·ã§ã³ãã©ã¯ãŒããŠããŒãæ®ãã®12ã¯ã12åã®ä»ã®å€©ç¶æåããšããŠäžè¬çã«èšåãããŠãããå®å šãªæåããã«ã®å ·äœæ§ãéåžžã¯é£çè£å©é£ååžå Žã®ããŒã¹ã©ã€ã³æåŸ å€ã§ããããšãèãããšã泚ç®ã«å€ããçç¥ã§ãã補åã¯åŠæ¹å»ã§ã¯ãªããæå¹æ§äž»åŒµã«å¯ŸããFAAäžåžåæ¿èªã®å¯Ÿè±¡ã§ã¯ãªããèšåºè©Šéšç»é²ã®é瀺ããããŸããããã®ã«ããŽãªã¯å€©ç¶é¢ç¯å¥åº·ãµããªã¡ã³ãã§ããã°ã«ã³ãµãã³ãã³ã³ããã€ãã³ããŠã³ã³ïŒã¯ã«ã¯ãã³ïŒãã³ã©ãŒã²ã³ããããããã¹ãŠã§ãªã¢æœåºç©ãå«ã確ç«ããããã¬ã€ã€ãŒãæã€æ¶è²»è ãŠã§ã«ãã¹åžå Žã§æå€§ãã€æãç«¶äºçãªãã®ã®ãã¡ã®1ã€ã§ãã
åžå Žããžã·ã§ãã³ã°ã¯ç©æ¥µçã«ç°ç«¯ã§ããRejuvaJointã¯æ¢åã®ãµããªã¡ã³ãã®ããè¯ãããŒãžã§ã³ã§ãããšäž»åŒµããŠããŸãããããã¯æ ¹æ¬çã«ç°ãªãã以åã«æå§ãããŠããã¡ã«ããºã ã§åäœãããšäž»åŒµããŠããŸãããã®ãã«ããŽãªãŒåµé ãã¯åããŸãã補åãé¢ç¯ãµããªã¡ã³ãåžå Žå ã§é 眮ããã®ã§ã¯ãªããããã®äžã«ãåžå Žå šäœãæäŸããããšããŠå€±æããŠãããœãªã¥ãŒã·ã§ã³ãšããŠïŒæå³çãã€æŽç·ŽãããæŠç¥çéžæã§ããããã¯å®å šã«å忝èŒåé¡ããã€ãã¹ããŸãã
ã¿ãŒã²ããã«ããŠããåé¡
é¢ç¯çãšæ ¢æ§é¢ç¯çã¯æ¬ç©ã®å€§èŠæš¡å ¬è¡è¡çè² æ ã衚ããŠãããããã¯ãŸãã«å¥åº·ããŒã±ãã£ã³ã°ã®è¥æ²ãªåå£ã«ãªããã®ã§ããçŸç 管çäºé²ã»ã³ã¿ãŒïŒCDCïŒã¯ãçŽ5,850äžäººã®ã¢ã¡ãªã«äººããªãããã®åœ¢ã®é¢ç¯çãšèšºæãããŠãããšæšå®ããŠããããã®æ°ã¯äººå£ã®é«éœ¢åã«äŒŽã2040幎ãŸã§ã«7,800äžäººã«éãããšäºæ³ãããŠããŸããCDCã®é¢ç¯çããã°ã©ã ããŒã¿ã«ãããšãå€åœ¢æ§é¢ç¯çã ãã§300äžäººä»¥äžã®ç±³åœæäººã«åœ±é¿ãäžããŠããŸããè²»çšã¯é©ç°çã§ããé¢ç¯ç財å£ã¯ãé¢ç¯çã¯ç±³åœã§å»çè²»ãšè³éåªå€±ã§å¹Žé3,000åãã«ä»¥äžãå ãããšæšå®ããŠããŸãããããã¯çºæãããåé¡ã§ã¯ãããŸãããèŠçã¯æ¬ç©ã§ãããèŠæš¡ã¯æ¬ç©ã§ãããæ ¢æ§å€æ§é¢ç¯ç¶æ ã®æ²»çã«ãããåŸæ¥å»åŠã®éçããæ¬åœã«æ¬ç©ã§ãã
å€åœ¢æ§é¢ç¯çã®åŸæ¥ã®æ²»çã¯äž»ã«æ²»çã§ã¯ãªã察ççæ³ã§ããNSAIDsã¯ççãšçã¿ã軜æžããŸãããé·æäœ¿çšã§å¿èè¡ç®¡ããã³èè žãªã¹ã¯ã䌎ããŸããã³ã«ãã³ã¹ããã€ã泚å°ã¯äžæçãªç·©åãæäŸããŸãããæœåšçãªé¢ç¯æªåã®ããé »ç¹ãªäœ¿çšã¯æšå¥šãããŸãããç©ççæ³ã¯æ¯æçèãæ§ç¯ããŸãããè»éªšåªå€±ãé転ãããŸãããé¢ç¯çœ®ææè¡ã¯æå¹ã§ãã䟵襲çã§ãããå€ç§çãªã¹ã¯ã䌎ããéåžž1ã2幎ã®å埩ãå¿ èŠã§ããç±³åœå»åŠäŒèªã¯ãä¿å®çãªé¢ç¯çæ²»çãžã®æ£è æºè¶³åºŠãéå®çã§ãããå€ãã®æ£è ãèä¹ æ§ã®ããç·©åãéæããããšãªãæ°å¹Žéæ²»çã埪ç°ãããããšã«æ³šç®ããè€æ°ã®åæãçºè¡šããŠããŸãããã®æ²»çã®ã£ããã¯VSLãæªçšããæ¬ç©ã®è匱æ§ã§ãããçºæããããã®ã§ã¯ãªãæ¬ç©ã®ã®ã£ããã§ãã
ããããVSLã¯ãã®ã®ã£ãããåã«ææãããããã¯ããã«é²ã¿ãŸããåŸæ¥ã®æ²»çãéå®çã§ã¯ãªãæå³çã«è©æ¬ºçãšããŠãæ£è ãäŸåããç æ°ã«ä¿ã€ããã«10åãã«èŠæš¡ã®åžå Žãç¶æããããã®è£œè¬äŒæ¥ã«ããå調çé°è¬ãšããŠç¹åŸŽä»ããŠããŸããã10åãã«ãã®NSAIDåžå Žæ°åã¯åžå ŽéèŠã§ã¯ãªãæå³ç害ã®èšŒæ ãšããŠåŒçšãããŸãããå»åŠã«ã¯éçãããããããå»åŠã¯åã§ããããžã®ãã®ããããã¯VSLãè¡ãéèŠãªã€ããªãã®ãŒçåãã§ãããèª¬åŸæç®ãåœã®æµãã¬ãŒã ãšããŠç¹å®ãããã®ã§ããå©çãèŠèŽè ã®å©çãšå¯Ÿç«ããæªåœ¹ã«ååãä»ããããšã§ãVSLã¯åæã«èŠèŽè ã®æ¬²æ±äžæºãæ€èšŒãã圌ãã®æ¹å倱æã説æããäžæ£çŽãªäžçã§ã®å¯äžã®æ£çŽãªä»£æ¿åãšããŠè£œåãé 眮ããŸãã
åé¡ã»ã¯ã·ã§ã³ã®ææ çãã¯ã¹ãã£ã¯ç²Ÿå¯ã«èª¿æŽãããŸããVSLã¯ãæ¯æ7人ã®é¢ç¯çæ£è ãç®ãéããŠãæ°žé ã«ãããã«çžãããŠããããšã«æ°ä»ãããšããå èçã§å人çãªçšèªã§èŠçãå®éåããŠããã人å£ã¬ãã«ã®çµ±èšã«ã¹ã±ãŒãªã³ã°ããŸããç¹å®ããéèšãžã®ãã®åãã¯ãããŒã«ã»ã¹ããŽã£ãã¯ãåæ ã®å¿çåŠã§èšé²ããä¿®èŸçæ§é ãåæ ããŠããŸããå人çãªèŠçã¯çµ±èšçãªèŠçãããã¯ããã«ä¿¡é Œã§ããå ±æãåŒãèµ·ãããVSLã¯åå¥ïŒããŒãµã»ã¹ãã¥ã¯ãŒããç¹å®ã®æ£è ïŒã§å§ãŸãåã«éå£èŠæš¡ã«åºãããŸãã
ä»ã®VSLããã®ãããã§ã©ã®ããã«ããããæ§é åããŠãããèå³ããããŸããïŒäžã®ã»ã¯ã·ã§ã³ãèªã¿ç¶ãããšãäžèšã®ãã¹ãŠã®äž»åŒµã®èåŸã«ããå¿çåŠãåãããŸãã
Arthrocel (RejuvaJoint) ã®ä»çµã¿
VSLã®äž»åŒµãããã¡ã«ããºã ã¯ãåäžã®éåžžã«ã·ã³ãã«ãªææ¡ã«çŠç¹ãåœãŠãŠããŸãïŒé¢ç¯çãšé¢ç¯çã¯ã³ã©ãŒã²ã³äžè¶³ã«ãã£ãŠåŒãèµ·ããããã³ã©ãŒã²ã³ã¬ãã«ãå埩ãããããšã§è»éªšãæ°žä¹ ã«ä¿®åŸ©ããçã¿ãæé€ããŸããããã¯ã³ãŒãã«å€§åŠå»åŠéšã®ãªãºå士ã®ããŒã ã«ããç ç©¶ã«èµ·å ããŸããè°è«ã¯æ¬¡ã®ããã«é²ã¿ãŸããã³ã©ãŒã²ã³ã¯è»éªšã®å®å šæ§ãç¶æããæ§é ã¿ã³ãã¯è³ªã§ããã³ã©ãŒã²ã³ã¬ãã«ãäœäžãããšãè»éªšãæªåããé¢ç¯ãççãèµ·ãããçã¿ãçããŸããåŸæ¥å»åŠã¯ççïŒäžæµã®çç¶ïŒãæ²»çããã®ã§ã¯ãªããäžè¶³ïŒäžæµã®åå ïŒãæ²»çããŸãããã·ã¥ããã¡ãœããã¯äžè¶³ã«çŽæ¥å¯ŸåŠããŸãã
ãžã§ã€ã³ãå¥åº·ãžã®ã³ã©ãŒã²ã³ã®éèŠæ§ã¯è£œé ããããã®ã§ã¯ãªããæ£åœã§æŽ»çºãªç ç©¶ã®é åã§ããè»éªšã¯ç¢ºãã«äž»ã«IIåã³ã©ãŒã²ã³ã§æ§æãããŠãããè»éªšã¯è¡ç®¡æ§é ããªãããïŒçŽæ¥è¡æ¶²äŸçµŠããªãïŒéå®çãªèªå·±ä¿®åŸ©èœåãæã£ãŠããŸããCurrent Medical Research and Opinionããã³International Journal of Medical Sciencesãå«ããžã£ãŒãã«ã«æ²èŒãããç ç©¶ã¯ãçµå£ã³ã©ãŒã²ã³ããããè£çµŠãå€åœ¢æ§é¢ç¯çæ£è ã®é¢ç¯çããããã«è»œæžããæ©èœãæ¹åããå¯èœæ§ãããããšãçºèŠããŸãããã广ãµã€ãºã¯äžè¬çã«å°ããäžçšåºŠã§ãããåéã¯æ±ºå®ãããŠããŸãããNIHã®åœç«è£å®çµ±åå¥åº·ã»ã³ã¿ãŒã¯ãã³ã©ãŒã²ã³ãµããªã¡ã³ãã¯ãäžè¬çã«å®å šãšèŠãªããããããæå¹æ§ã®èšŒæ ã¯äºåçãªãŸãŸã§ãããšè¿°ã¹ãŠããŸãã
VSLã®ã¡ã«ããºã ãæç®ããéžè±ããå Žæã¯ãã®çµ¶å¯Ÿæ§ã§ããã³ã©ãŒã²ã³äžè¶³ãåãªãå¯äžèŠå ã§ã¯ãªãããã®ãæ ¹æ¬åå ã§ãããèåãæ©æ¢°çæ©èãèªå·±å ç«ããã»ã¹ïŒé¢ç¯ãªãŠãããªã©ïŒã代è¬èŠå ãããã³éºäŒççŽ å ãäžåããšãã䞻匵ã§ããããã¯ç§åŠæç®ãæ¯æããªãéèŠãªé床ãªåçŽåã§ããå€åœ¢æ§é¢ç¯çã¯è€éã§ãã«ããã¡ã¯ããªã¢ã«ãªçŸæ£ãšçè§£ãããŠããŸãããã·ã¥ããæ ¹æœåºç©ãç¹ã«ãã³ã©ãŒã²ã³ç£çãåºæ¿ãããã§ãããããã·ã§ã³ãã©ã¯ãŒç²æ«ããè¡æ¶²ããããã¯ã¹ããŠãã³ã©ãŒã²ã³åžåãå¯èœã«ãããšãã䞻匵ã¯ããããã®ç¹å®ã®æåããããã®ç¹å®ã®ã¡ã«ããºã ã«å¯Ÿããç¬ç«ããç ç©¶ãžã®åŒçšãªãã§æç€ºãããŸããæ³šç®ã«å€ãããã¿ãŒã³ãVSLã®èšåºè©Šéšæ°åïŒ1,571人ã®åå è ã®ãã¡1,565äººãæ°žä¹ ã«çã¿ããªãã99.6%ã®æåçã衚ããæ¢ç¥ã®ãã¹ãŠã®å»åŠçãŸãã¯å€ç§çé¢ç¯çä»å ¥ã®çºè¡šãããæå¹æ§ãè¶ ããçå®ã®å ŽåãçŸä»£å»åŠã®æãéèŠãªå»åŠçºèŠãæ§æããã§ãããããã®æ°åã®åœåããããžã£ãŒãã«ã詊éšç»é²çªå·ããŸãã¯çºè¡æ¥ããªãããšã¯ãéèŠãªä¿¡é Œæ§ã®ã£ããã§ãã
äž»èŠæåãšã³ã³ããŒãã³ã
VSLã¯2ã€ã®äž»èŠæŽ»æ§æåã«ååãä»ãã12ã®è¿œå æåãæå®ããã«åç §ããŸãããã®éšåçãªé瀺ã¯ããèªäœãããŒã±ãã£ã³ã°éžæã§ããåœåãããæåã¯æ³ååãããç«ãŠãŠèšæ¶ã«æ®ãããããªããåœåãããŠããªã12ã¯ç¬èªã®è€éãã®ç©ºæ°ãä¿ã¡ãŸãã以äžã¯ãé瀺ãããæåã«é¢ããç¬ç«ããç ç©¶ãè¿°ã¹ãŠããããšã§ãïŒ
ãã·ã¥ããæ ¹æœåºç©ïŒAlthaea officinalisïŒïŒ ãã·ã¥ããæ ¹ã¯æ¶ååšããã³åŒåžåšçç¶ã®äŒçµ±çãªæ²»çæ³ã§ãããã®ç²æ¶²ç©è³ªïŒäž»ã«ããªç³é¡ïŒã¯ããã€ãã®è©Šéšç®¡ããã³åç©ç ç©¶ã§æççç¹æ§ã瀺ããŠããŸãã2013幎ã®Journal of Ethnopharmacologyã®ã¬ãã¥ãŒã§ã¯ãççç¶æ ã®äŒçµ±çãªçšéã«èšåããŸãããããããããé¢ç¯çŸæ£ã§ã®è»éªšåçãŸãã¯ã³ã©ãŒã²ã³åæåºæ¿ã«é¢ããæ»èªæžã¿èšåºèšŒæ ã¯ãçºè¡šãããæç®ã§ã¯ç¢ºç«ãããŠããŸããããé¢ç¯ã§ã³ã©ãŒã²ã³ç£çãåºæ¿ããããšããVSLã®äž»åŒµã¯ãå©çšå¯èœãªèšåºè©ŠéšããŒã¿ã«ãã£ãŠãµããŒããããŠããŸããã
ããã·ã§ã³ãã©ã¯ãŒããŠããŒïŒPassiflora incarnataïŒïŒ ããã·ã§ã³ãã©ã¯ãŒã¯ããã®æäžå®ããã³è»œåºŠã®é®éç¹æ§ã«ã€ããŠããäžè¬çã«ç ç©¶ãããŠãããäžå®ããã³ç¡ç å質ã®çšéããµããŒãããããã€ãã®ç ç©¶ããããŸããPhytotherapy ResearchïŒ2011幎ïŒã«æ²èŒãããç ç©¶ã§ã¯ãäœçšéãªããµãŒãã ã®å šè¬æ§äžå®ã«å¯Ÿå¿ããæ§ãçºèŠããŸãããVSLã§ã®ææ¡ããã圹å²ã§ãããé·æçãªçã¿è¬ã®ååŠç圱é¿ããè¡æ¶²ãã¯ã¬ã³ãžã³ã°ããŠãã³ã©ãŒã²ã³åžåãå¯èœã«ããã¯ãæ©æ§çã«æ°èŠã§ãããæ¢ç¥ã®è¬çåŠçç ç©¶ã«ãã£ãŠã¯ãµããŒããããŠããŸããããã®ææ¡ãããè¡åã¯ã確ç«ãããç§åŠãšããããææ©çãªå€æ¿æ³ã§ãã
åœåãããŠããªã12ã®è¿œå å€©ç¶æåïŒ é瀺ããªããããç¬ç«ããè©äŸ¡ã¯äžå¯èœã§ããé£çè£å©é£åã®ã³ã³ããã¹ãã§ã¯ã匷ãæå¹æ§äž»åŒµãè¡ã補åã®å Žåãããã¯ç°åžžãªéžæã§ãããå»åž«ãŸãã¯è¬å€åž«ãå®å šçžäºäœçšãè©äŸ¡ããèœåãå¶éããŸãã
ããã¯åºåè§åºŠ
VSLã®ãªãŒããã³ã°ããã¯ããçŸä»£å»åŠãé¢ç¯çãšé¢ç¯çã«ã€ããŠç¥ã£ãŠãããšæã£ãŠããããšã¯ãä»ãæ·±å»ãªçåã«ãããããŠããŸããããã¿ãŒã³å²ã蟌ã¿ãšããŠæ©èœããŸãïŒCialdiniã2006ïŒïŒèŠèŽè ã®æåŸ ãããèªç¥ãããŒã®äžæãéèŠãªéèŠæ§ã®æ å ±ã瀺ããŸãããã¬ãŒãºã¯ã¢ãŒããã¯ãã£çã«æ éã§ããå»åŠãééã£ãŠãããšäž»åŒµããŸããïŒããã¯å³åº§ã®æççæèãããªã¬ãŒããŸãïŒãå»åŠã®ç¢ºå®æ§ã¯ä»ããçåäžã«ããããšäž»åŒµããŠããŸãïŒããã¯è²¬ä»»ããç§åŠçæ¹æ£ã®ããã«èãããŸãïŒãååçæ§é ã§ãããä»ãæ·±å»ãªçåã«ãããããŠããŸãããå€éšã®ä¿¡é Œã§ããå°åãããåäžã®ç°ç«¯è ã®å£°ã§ããããšãæå³ããã¹ããŒãã¡ã³ãã«å®éã«æã€ããšã®ãªãæ©é¢çãªéã¿ãäžããŸãã
ããã¯ããã¹ããã㯠Eugene Schwartz ã¹ããŒãž4åžå Žæç床ã®åãã§ããSchwartz ã®ã¢ãã«ã¯ãè³Œå ¥è ããã¹ãŠã®çŽæ¥çãªçŽæãšãã¹ãŠã®è£œåã«ããŽãªäž»åŒµãèŠãæçåžå Žã§ã¯ãå¯äžã®å¹æçãªãšã³ããªãŒãã€ã³ãã¯æ°ããã¡ã«ããºã ã§ãããšè¿°ã¹ãŠããŸããè³Œå ¥è ãç¥ã£ãŠãããšæã£ãããšãééã£ãŠããã以åã¯æªç¥ã®ããã»ã¹ã圌ãã®æ¹å倱æã説æãããšãã䞻匵ãç±³åœã®é¢ç¯çãµããªã¡ã³ãåžå Žã¯é£œåããŠããŸããã°ã«ã³ãµãã³ã¯æ°å幎åãããããŸãããã³ã©ãŒã²ã³ããããç²æ«ã¯ã³ã¹ãã³ã§è²©å£²ãããŠãããå¹³åçãªè³Œå ¥è ã¯ãã®äººå£çµ±èšã§å°ãªããšã2ã€ãŸãã¯3ã€ã®ãµããªã¡ã³ãã詊ããŠããŸããããã¯ã¯ãããè¯ãé¢ç¯ãµããªã¡ã³ãããšèšããªãã®ã§æ£ç¢ºã«æ©èœããŸãïŒãã¹ãŠã®ããšãããªããèšããããã¹ãŠãééã£ãŠãããšèšãããããã¯ç²ãåã£ããæççãªãªãŒãã£ãšã³ã¹ã«æµžéããããšãã§ããå¯äžã®ãã¬ãŒã ã§ãã
VSLã§èгå¯ãããäºæ¬¡ããã¯ïŒ
- ãé¢ç¯çãšé¢ç¯çã«ã€ããŠããªããç¥ã£ãŠãããã¹ãŠãåã§ãããã¢ã€ãã³ãã£ãã£ã®è åšãšé°è¬ãã¬ãŒãã³ã°
- ã補è¬äŒæ¥ã¯ãã®æ å ±ãæå§ããããšããŠããŸããåé€ãããåã«èŠãŠãã ããããæ€é²ã®è åšãéããŠè£œé ãããç·è¿«æ
- ãããŒãµã»ã¹ãã¥ã¯ãŒãã¯åæã®14æ¥åã«ããã«æãããŸããããæ¥µç«¯ãªã¹ããŒã¯ã¹ã§ã»ã¬ããªãã£å±æ©ãã©ãã£ã
- ãææ°ã®æå 端ã®é¢ç¯çæ²»çãã9å广çããå®éåãããåªäœæ§äž»åŒµ
- ã7人ã®é¢ç¯çæ£è ã¯æ¯æç®ãéããŠãæ°žé ã«ãããã«çžãããŠããããšã«æ°ä»ãããå èçãªçµ±èšçåå¥å
Meta ãŸã㯠YouTube ã¡ãã£ã¢è³Œå ¥è åãã®åºåèŠåºãã®ããªãšãŒã·ã§ã³ïŒ
- ããªãºå士ã®2æåã¬ã·ããé¢ç¯çãå€ç§æè¡ãªãã§é転ããããå»è ã¯æ¿æããŠããã
- ã73,000人ã®ã¢ã¡ãªã«äººããã®ã·ã³ãã«ãªèªç¶ãªæ¹æ³ã䜿çšããŠé¢ç¯çãæé€ããã
- ãé¢ç¯çã®æ¬åœã®åå ã¯ççãšã¯äœã®é¢ä¿ããããŸããïŒã¹ã¿ã³ãã©ãŒãã¯èšãïŒã
- ãããŒãµã»ã¹ãã¥ã¯ãŒãã¯äºåºŠãšæ©ããªããšèšãããŸããããããŸã§ã®ãšããã
- ãNSAIDs ã®ç¡é§ãªãéïŒBig Pharma ãããªãã«èšããªãã³ã©ãŒã²ã³ã®ç§å¯ãæ¢ããã
å¿ççããªã¬ãŒãšèª¬åŸæŠè¡
VSLã®èª¬åŸã¢ãŒããã¯ãã£ã¯ç¬ç«ããæŠè¡ã®å¹³è¡ã¹ã¿ãã¯ã§ã¯ãªããåã¬ã€ã€ãŒãåã®ã¬ã€ã€ãŒãå¢å¹ ããæ éã«é åãããèç©ã§ããæçŽã¯æš©éïŒã¹ã¿ã³ãã©ãŒãããªãºå士ïŒã§å§ãŸããææ çãªã¢ã€ãã³ãã£ãã¡ã€ïŒããŒãµã»ã¹ãã¥ã¯ãŒãã®ç¬ç«åªå€±ïŒã«ç§»åããææã«ãšã¹ã«ã¬ãŒããïŒåæãè»æ€ åãæ°žé ã«ãããã«çžãããïŒãæªåœ¹ãå°å ¥ãïŒè£œè¬äŒæ¥ïŒããšããã¡ããŒãé ä¿¡ããŸãïŒã³ã©ãŒã²ã³äžè¶³ãæ¬åœã®åå ã§ãïŒãçµ±èšã§èšŒæããŸãïŒ73,000人ã®ãŠãŒã¶ãŒã99.6%ã®è©ŠéšæåïŒãåžå°æ§ãšåªå€±åæªã§éããŸãããã®ã·ãŒã±ã³ã¹ã¯è¡åçµæžåŠã奜ã¿ã®æ§é ãšåŒã¶ãã®ãåæ ããŠããŸããè³Œå ¥è ã¯åºå®ããã奜ã¿ã§å°çããªããšããèãã§ãããåãåã£ãæ å ±ã«ãã£ãŠãªã¢ã«ã¿ã€ã ã«æ§ç¯ãããŸããäŸ¡æ Œãæããã«ãããæç¹ã§ãèŠèŽè ã®å¥œã¿ã¯6ã€ã®ç°ãªãèª¬åŸæ®µéãéããŠæ§ç¯ãããŠããŸãã
æçµçãªæ°åã§ã®ãªãã¡ãŒæ§é ã¯ç¹ã«æŽç·ŽãããŠããŸãã$2,000ã®ã³ã¹ã ã¢ã³ã«ãŒãåé€ãããããã«$79ã®ããã«ã«è»åãããã3ã€è³Œå ¥æã«3ã€ç¡æãããã¢ãŒã·ã§ã³ã«ããåæžãã$894ã®å°å£²äŸ¡å€ã¯$294ã®åèšã䞊å€ããç¯çŽãšããŠãã¬ãŒãã³ã°ããŸããåäŸ¡æ Œåé€ã¯èŽãç©ã®ããã«æããããŸããThaler ã®è³Šäžå¹æã®é åãããã§äœãç¡æïŒ3ã€ã®ããã«ïŒãåãåãæèŠãè³Œå ¥åã«æææš©ã®ææ ãããªã¬ãŒããŸãã
çè«ã«åºã¥ããç¹å®ã®æŠè¡ïŒ
æš©é転éïŒCialdiniïŒïŒ ã¹ã¿ã³ãã©ãŒãããžã§ã³ãºã»ãããã³ã¹ãããŒããŒããã³ãŒãã«ãããã³ããŠã³ãã»ã·ãã€ã«èšåãããŠããã補åãæ€èšãŸãã¯æ¿èªããæ©é¢ãšããŠã§ã¯ãªããç ç©¶ã宿œãããå ŽæãŸãã¯ããŒãµãæ²»çãããå ŽæãšããŠãçŸåšã®æšå¥šãè¡ããã«é»ç€ºçã«æšå¥šãäœæãã埮åŠãªåºå¥ã§ãã
åªå€±åæªïŒKahneman ãš TverskyãProspect Theoryã1979ïŒïŒ ãè¢åæãããæ°žé ã«ãããã«çžããããããæ°žç¶çãªé害ãã®ææªã®å Žåã®çµæã®é®®ãããªç¹°ãè¿ãã®èª¬æã¯ãäžäœçšã®çã¿ããã確å®ã§ããå³åº§ã§ããè³Œå ¥ã®äžç¢ºããªå©çãããæããããŸããæå€±ã¯å©çãããã¯ããã«å€§ããèŠããŸãã
åœã®æµãã¬ãŒãã³ã°ïŒGodin ã®éšæïŒïŒ 補è¬äŒæ¥ã¯å ±æãããæµãšããŠåä»ããããèŠèŽè ãšãã¬ãŒã¿ãŒã®éã§ã€ã³ã°ã°ã«ãŒãã®èº«å ãäœæããŸãã補åãè³Œå ¥ããããšã¯è æãã確ç«ã«å¯Ÿããéšæã®å¿ èª è¡çºã«ãªããŸãã
ãšããã¡ããŒæ©ïŒBrunsonïŒïŒ ãªãºå士ã¯åœŒèªèº«ã®å®çŸã®ç¬éãèªããå®¶ãé転ããããŒãµã®åŒã³åºããåãåããåŸæ¥å»åŠã倱æããããšãèªèããŠãããèŠèŽè ãåãèªç¥ã·ãããçµéšããããæåŸ ããŸãã補åã¯ãã®å ±æããããšããã¡ããŒã®ç©ççãªã¢ãŒãã£ãã¡ã¯ãã§ãã
瀟äŒç蚌æ ã¹ã¿ããã³ã°ïŒCialdiniïŒïŒ å¿åã®èšŒèšãã»ã¬ããªãã£ã®èšŒèšããŠãŒã¶ãŒæ°ïŒ73,000ïŒãããã³èšåºè©Šéšçµ±èšã¯ç¹å®ã®é åºã§ã¬ã€ã€ãŒãããŠãããèåæ§ãé«ãæåã®ã»ã¬ããªãã£ïŒä¿¡é Œæ§åŒ·åïŒã次ã«çµ±èšãæåŸã«å¿åã®èšŒèšïŒèå¥ïŒã§ãå§åçãªã³ã³ã»ã³ãµã¹ã®å°è±¡ãäœæããŸãã
èªç¥äžååïŒFestingerã1957ïŒïŒ èŠèŽè ã¯ãçŸåšã®è¡åïŒNSAIDs ãæçšããå»åž«ã®ã¢ããã€ã¹ã«åŸãïŒãç¶ç¶ããããšããç¡å¹ã§ãããã€ç©æ¥µçã«æå®³ã§ãããšèšãããŠããŸããããã«ããã圌ãã®è¡åãšå¥åº·ãžã®æ¬²æã®éã«äžååãçãã補åãè³Œå ¥ããããšã§è§£æ±ºãããŸãã
人工çåžå°æ§ïŒCialdini ã®åžå°æ§ååïŒïŒ 355åã®ããã±ãŒãžã10åã¿ã€ããŒãå ¬åŒãŠã§ããµã€ãã®ã¿ããã¹ãŠãçæ§çãªäŸ¡æ Œæ¯èŒãšæ€èšãäžæããå€å žçãªè£œé åžå°æ§ã¡ã«ããºã ã§ãã
ãããã®æŠè¡ãå¥åº·ãšãŠã§ã«ãã¹ç©ºéã§ 50 以äžã® VSL ã§ã©ã®ããã«æ¯èŒãããããèŠããã§ããïŒããã¯ãŸãã« Daily Intel Service ã衚瀺ããããã«æ§ç¯ããããã®ã§ãã
ç§åŠããã³æš©éã·ã°ãã«
VSLã¯ããªãã®ã¹ãã«ã§æ©é¢çæš©éãå±éããŸãããæ éãªèªã¿ã¯ãåœåãããæ©é¢ã®ã©ãããé瀺ãããŠããªãããšãæããã«ããŸããã¹ã¿ã³ãã©ãŒãããžã§ã³ãºã»ãããã³ã¹ãããŒããŒããã³ãŒãã«ãããŠã³ãã»ã·ãã€ïŒç¬ç«ããŠæ€èšŒå¯èœãªæ¹æ³ã§åŒçšãããŸããã¹ã¿ã³ãã©ãŒãç§åŠè ã¯ããã¬ãŒã¯ã¹ã«ãŒã®æç¢ºãªå åã瀺ããŠããããžã§ã³ãºã»ãããã³ã¹ã¯ããŠãŒã¶ãŒæ°ãæããã«ããŠãããã³ãŒãã«ã®å»åŠéšã¯ã³ã©ãŒã²ã³çºèŠãè¡ãããå Žæã§ããããŒããŒããã¹ã¿ã³ãã©ãŒãããžã§ã³ãºã»ãããã³ã¹ã¯ããã·ã¥ããã¡ãœãããèªèããŸãããããããã®åç §ã¯ãç¬ç«ããæ€èšŒãå¯èœã«ããèè åãçºè¡æžåããžã£ãŒãã«åãæ¥ä»ããŸãã¯è©³çްãå«ã¿ãŸãããããã¯ãªãºå士ã®äœ¿çšã¯ãæ©é¢ç芳ç¹ããç¹ã«éèŠã§ããã¡ãã¡ããã»ãªãºåå£«ã¯æ¬ç©ã®äººç©ã§ãå å¿èžéšå€ç§å»ãå ãªãºå士ã·ã§ãŒãã¹ããããã³å ç±³åœäžé¢åè£è ã§ããã®ååãšç»åã¯ç®æšäººå£çµ±èšã®äžã§æ¬ç©ã®èªèãéã³ãŸãããããããªãºå士ã®ãã©ã³ãã¯ãå¥åº·è£œåã®æ¿èªã«é¢ããæ°å€ãã®FTCããã³FDAé¢é£ã®è«äºã«é¢ãã£ãŠããŠããããªãºå士ã Arthrocel ãŸã㯠RejuvaJoint ãéçºãæ¿èªããŸãã¯ææºããŠããããšã¯å ¬éãããŠããŸããããã®VSLã§ã®ãªãºå士ã®ã¢ã€ãã³ãã£ãã£ã®äœ¿çšã¯ããã¬ãŒã¿ãŒããã³ã¯ã¬ãžãããããçºæå®¶ã®äž¡æ¹ãšããŠãæ€èšŒãããå®éã®ææºã®é瀺ãªãã§ãåçšãããæš©éãæ£åœãäžæ£ãã«ã€ããŠç©è³ªçãªè³ªåãæèµ·ããŸãããã®è£œåãç ç©¶ããŠããèªè ã¯ãå¥åº·ããŒã±ãã£ã³ã°ã®ã»ã¬ããªãã£åãå®éã®æ¿èªã瀺ãå¿ èŠããªãããšã«æ°ã¥ãã¹ãã§ãã
èšåºè©Šéšã®æ°åã§ãã1,565ã®ãã¡1,571人ã®åå è ãçã¿ããªãã¯ãä¿¡é Œã§ããèšåºç ç©¶ã®æšæºããŒã«ãŒã®ãããããªãã§ã¹ã¿ã³ãã¢ãã³çµ±èšãšããŠæç€ºãããŸããæ©é¢ã䞻任調æ»è ããžã£ãŒãã«ãNCTç»é²çªå·ãåºçæ¥ã99.6%ã®æ°žç¶çãªçã¿æé€çã¯é¡é¢šæ¹¿æ§é¢ç¯çã®æŽå²ã®äžã§æãçµ±èšçã«éèŠãªçºèŠã«ãªãã§ããããPubMed ãŸã㯠ClinicalTrials.gov ãéããŠã¢ã¯ã»ã¹å¯èœãªå»åŠæç®ã®ãããã«ãååšããªãããšã¯ãæ éãªèªè ã«ãã£ãŠéèŠãªä¿¡é Œæ§ã·ã°ãã«ãšããŠæ±ãããã¹ãã§ãã
ãªãã¡ãŒãäŸ¡æ Œãããã³ãªã¹ã¯å転
ãã®VSLã®ãªãã¡ãŒååŠã¯ããã®æãæè¡çã«éæãããèŠçŽ ã®äžã«ãããŸããäŸ¡æ Œã·ãŒã±ã³ã¹ã$2,000ïŒæåã³ã¹ãã¢ã³ã«ãŒïŒããã®åŸ$894ïŒå°å£²å€ïŒããã®åŸ$79ã®ããã«ïŒæšæºäŸ¡æ ŒïŒããã®åŸ$49ã®ããã«ïŒããã¢ãŒã·ã§ã³ã3ã€è³Œå ¥æã«3ã€ç¡æïŒãå®éã®è²©å£²äŸ¡æ Œã«å°éããåã«4ã€ã®ç°ãªãäŸ¡æ Œãã¬ãŒã ãå®è¡ããŸããããã¯å€æ®µéäŸ¡æ Œã¢ã³ã«ãŒæŠç¥ã§ãããåäžéäŸ¡æ Œã¯æ¬¡ã®åæžãããæ¥µç«¯ã«æãããããããæçµçãª$49ã®æ°åã¯èŠèŽè ã®äºåã®é¢å¿ãäœãã»ãã«ã¡ã³ãè²»çšãšããæèã«å¯ŸããŠã§ã¯ãªãã40ååã«å°å ¥ããã$2,000ããŒã¹ã©ã€ã³ã«å¯ŸããŠè©äŸ¡ãããŸãã$2,000ã®æ°åãå®éã®ã³ã¹ãã衚ããã©ããã¯VSLåç¬ããã¯æ€èšŒã§ããŸããã
60æ¥éã®è¿éä¿èšŒã¯æ¬ç©ã®ãªã¹ã¯å転ãšããŠæ©èœããŸãïŒè³Œå ¥è ãã売ãæãžã®è©Šéšã®ééçãªã¹ã¯ãç§»åããè³Œå ¥ã«å¿ èŠãªã¢ã¯ãã£ããŒã·ã§ã³ ãšãã«ã®ãŒãåæžããŸããçŽæ¥å¯Ÿå¿ãµããªã¡ã³ãæ¥çã§ã¯ã60æ¥éã®ä¿èšŒã¯äŸå€çã§ã¯ãªãæ¥çæšæºã§ãããã ããããã§ã¯èŠå¶èŠç¯ã§ã¯ãªãå人çãªä¿¡é Œã®ãžã§ã¹ãã£ãŒãšããŠãã¬ãŒãã³ã°ãããŠããŸããç·è¿«æãã¬ãŒãã³ã°ã355ããã±ãŒãžã10åãŠã£ã³ããŠããããªãçµäºãããšãã«äŸ¡æ Œãæå¹æéåããã¯ããã®è«æ±ããããã©ã¡ãŒã¿ãã»ãŒç¢ºå®ã«æåéãã§ã¯ãªãæšæºçãªåžå°æ§ã¡ã«ããºã ã§ããããŒãžãªãã¬ãã·ã¥æã«ãªã»ãããããåçã«ãŠã³ãããŠã³ã¿ã€ããŒã¯ããã®ã«ããŽãªã®æ¢ç¥ã®æŠè¡ã§ããããç±³åœå šäœã®ããã®355ããã±ãŒãžãã®äž»åŒµã¯ãæ¢ã«73,000人ã®ãŠãŒã¶ãŒã«å°éãããšäž»åŒµãããŠãã補åã«å¯Ÿããæ¬ç©ã®åšåº«å¶çŽãšããŠä¿¡é Œæ§ãæŒãã€ã¶ããŠããŸãã
ããã¯èª°ã®ããã®ãã®ãïŒãããŠèª°ã®ãã®ã§ã¯ãªããïŒ
ãã®VSLãå°éããããã«èšèšãããçæ³çãªè³Œå ¥è ã¯ãç¹å®ã®æ¬ç©ã®äººç©ã§ããåŸæ¥ã®æ²»çã§é©åã«å¶åŸ¡ãããŠããªãæ ¢æ§é¢ç¯çãæ±ããŠãã55ã75æ³ã®ç±³åœäººã§ãçµæã®ãªããµããªã¡ã³ããŸãã¯å»è¬åã«æ¬ç©ã®ãéãè²»ãããç¬ç«ã倱ããå®¶æã«è² æ ããããããŸãã¯å€ç§çä»å ¥ã«çŽé¢ããããšã«ã€ããŠã®èæ¯äžå®ãæ±ããŠãã人ç©ããã®äººç©ã¯ããããããªãã®éã®ãããªã³ã³ãã³ããèŠãŠããããªãºå士ã®ååã奜æçã«èªèãããã®ãããªãäœæãŸãã¯å¢å¹ ããã®ã§ã¯ãªãããã®ãããªããåã«ãã補è¬äŒæ¥ã«å¯Ÿããæçãæã£ãŠããŸãããããã®ææ çãªã³ã¢ããèªåã®èªç±ã倱ããããæ§ç¯ããã©ã€ãããèããŠãããç§ã®æªå€¢ããå 霢ããæäººã圌ãã®èº«äœèœåã®åçž®ãèŠãŠããç¹å®ã®æ²ãã¿ãæ£ç¢ºã«è©±ããŸãããã®äººç©ã«ãšã£ãŠããããªã¯æ¬åœã®ãã®ã«ååãä»ããããçéžããŠããŸãã
補åã¯ããäžé©åã§ãããããã€ãã®ã«ããŽãªã®èªè ã«ãšã£ãŠæœåšçã«åé¡ããããŸãã蚺æãããèªå·±å ç«åœ¢æ ã®é¢ç¯çïŒé¢ç¯ãªãŠãããä¹Ÿç¬æ§é¢ç¯çãåŒ·çŽæ§èæ€çïŒãæã€èª°ãããVSLã®ææ¡ãããã¡ã«ããºã ïŒã³ã©ãŒã²ã³äžè¶³ãå¯äžã®åå ïŒããããã®ç¶æ ã®å ç«ç çã«å¯Ÿå¿ããŠããªãããšãèªèããå¿ èŠããããŸããå ç«ã·ã¹ãã ãã³ã©ãŒã²ã³ã¬ãã«ã«é¢ä¿ãªãé¢ç¯çµç¹ãæ»æããå ŽæãçŸåšãåŠæ¹å»è¬åã§é¢ç¯çã管çããŠãã誰ãã¯ãæªç¥ã®å®å šãªæåé瀺ãæã€ãµããªã¡ã³ããå°å ¥ããåã«å»åž«ã«çžè«ããå¿ èŠããããŸããæœåšçãªçžäºäœçšãªã¹ã¯ãäžããããŠããŸãããã®è£œåãå»åž«ãæšå¥šããå€ç§çä»å ¥ã®ä»£æ¿åãšããŠè©äŸ¡ããŠãã誰ãã¯ããã®æ±ºå®ã«ãµããããæ·±å»ãã§æ±ãå¿ èŠããããŸããVSLã®äž»åŒµã¯ãé床ã®é¢ç¯çã®æ£è ã®9ã®ãã¡10ã¯ãå®å šã«ç¶æ ãé転ããããµããªã¡ã³ãçæ³ãéããŠæè¡ãé¿ããããšããã®ã¯ãç¬ç«ããŠæ€èšŒå¯èœãªãœãŒã¹ã«ãã£ãŠç¢ºèªãããŠããŸããã
ãã®ã¿ã€ãã®VSLãä»ã®é¢ç¯å¥åº·ããããšã©ã®ããã«æ¯èŒããããã®å®å šãªå èš³ãå¿ èŠã§ããïŒDaily Intel Service ã¯æ°åãåæããŠããŸããèªã¿ç¶ããŠãæçµçãªã±ãŒã¹ãã©ã®ããã«ã¹ã¿ãã¯ããããã確èªããŠãã ããã
ãããã質å
QïŒRejuvaJoint ã¯è©æ¬ºã§ããïŒ
AïŒè£œåã¯è²©å£²ã®ããã®æ¬ç©ã®ãµããªã¡ã³ããšããŠååšããããããéãåã£ãŠãã以å€ãæäŸããªããšããåºæ¬çãªæå³ã§ã®è©æ¬ºçã§ã¯ãããŸãããããããVSLã§äœãããå€ãã®äž»åŒµãã»ã¬ããªãã£æ¿èªãæ©é¢çææºãèšåºè©Šéšæ°åãããã³äœçšã®ã¡ã«ããºã ã¯ãç¬ç«ããŠæ€èšŒããããšã¯ã§ãããããã€ãã®å Žåã¯ç¢ºç«ãããç§åŠãšççŸããããã«èŠããŸããèªè
ã¯ã賌å
¥ããåã«ããŒã±ãã£ã³ã°äž»åŒµã«å€§ããªæçãæã£ãŠæ¥è¿ããå»åž«ã«çžè«ããå¿
èŠããããŸãã
QïŒãªãºå士ã¯å®éã« RejuvaJoint / Arthrocel ãäœæãŸãã¯æ¿èªããŸãããïŒ
AïŒã¡ãã¡ããã»ãªãºå士ã Arthrocel ãŸã㯠RejuvaJoint ãéçºãæ¿èªããŸãã¯ææºããŠããããšã確èªããå
¬éå¯èœãªããã¥ã¡ã³ããŒã·ã§ã³ã¯ãããŸããããªãºå士ã®ååãšç»åã¯ãæ€èšŒãããææºããªãæ§ã
ãªãµãŒãããŒãã£å¥åº·è£œåããã¢ãŒã·ã§ã³ã«è¡šç€ºãããŠããŸãã賌å
¥è
ã¯ããã©ã³ããæ€èšŒå¯èœãªé瀺ãæäŸããªãéãããããªã§ã®åœŒã®åºçŸãæ¬ç©ã®æ¿èªãæ§æãããšä»®å®ãã¹ãã§ã¯ãããŸããã
QïŒArthrocel RejuvaJoint ã®å®éã®æåã¯äœã§ããïŒ
AïŒVSLã¯ããã·ã¥ããæ ¹æœåºç©ïŒAlthaea officinalisïŒãšããã·ã§ã³ãã©ã¯ãŒããŠããŒïŒPassiflora incarnataïŒã®2ã€ã®äž»èŠãªæåãé瀺ãã12ã®è¿œå ã®åœåãããŠããªãå€©ç¶æåãåç
§ããŠããŸããå®å
šãªæåããã«ã¯VSLã§ã¯é瀺ãããŠããŸãããé£çè£å©é£åã賌å
¥ããåã«ãå®å
šãªãµããªã¡ã³ãäºå®ã©ãã«ã確èªããããšã¯å©èšå¯èœã§ãã
QïŒãã·ã¥ããã¡ãœããã¯æ¬åœã«é¢ç¯çã«å¹æããããŸããïŒ
AïŒãã·ã¥ããæ ¹ã¯å®éšå®€ç ç©¶ã§æççç¹æ§ã®äžéšã瀺ããŠãããçµå£ã³ã©ãŒã²ã³è£çµŠã¯æ»èªæžã¿æç®ã§é©åºŠãªèšŒæ ãæã£ãŠããŸãããããããã®VSLã§è¡ãããç¹å®ã®äž»åŒµãæ°žç¶çãªè»éªšé転ã99.6%ã®èšåºè©Šéšæåçãããã³ç涯ã®é¢ç¯çæé€ã¯ã倩ç¶ãµããªã¡ã³ããŸãã¯ãããã®ä»»æã®çµã¿åããã®å©çšå¯èœãªç ç©¶ãæ¯æãããããã¯ããã«é²ã¿ãŸãã
QïŒRejuvaJoint ãæçšããããšããå¯äœçšããããŸããïŒ
AïŒå®å
šãªæåãªã¹ããå
¬éãããŠããªããããVSLåç¬ããã®å
æ¬çãªå®å
šæ§è©äŸ¡ã¯äžå¯èœã§ãããã·ã¥ããæ ¹ã¯æšæºçšéã§äžè¬çã«å®å
šãšèŠãªãããŸããããã·ã§ã³ãã©ã¯ãŒã¯åççãªå®å
šæ§ãããã¡ã€ã«ãæã£ãŠããŸãããé®éè¬ãšè¡æ¶²åžéè¬ãšçžäºäœçšããå¯èœæ§ããããŸããåŠæ¹å»è¬åãæçšãŸãã¯æ
¢æ§å¥åº·ç¶æ
ã管çããŠãã誰ãã¯ãæ°ãããµããªã¡ã³ãã远å ããåã«å»åž«ã«çžè«ããå¿
èŠããããŸãã
QïŒåŠæ¹ãããé¢ç¯çè¬ã®ä»£ããã« RejuvaJoint ã䜿çšããã®ã¯å®å
šã§ããïŒ
AïŒå»åŠçç£ç£ãªãã«å»åž«ãåŠæ¹ããå»è¬åã®ä»£ããã«é£çè£å©é£åã眮æããããšã¯ãå©èšå¯èœã§ã¯ãããŸãããVSLã¯ç©æ¥µçã«èŠèŽè
ã NSAIDs ãä»ã®åŸæ¥ã®æ²»çãæŸæ£ãããã奚å±ããŠããŸããããã®æšå¥šã¯ä»»æã®å人ã®å¥åº·å±¥æŽã®ç¥èãªãã§ãªãããŠããŸããåŠæ¹å»è¬åãçªç¶ã«åæ¢ãããšãçµæãããå¯èœæ§ãããããµããªã¡ã³ãã®æå¹æ§äž»åŒµã¯ç¬ç«ããèšåºç ç©¶ã«ãã£ãŠæ€èšŒãããŠããŸããã
QïŒRejuvaJoint ãæ©èœããã®ã«ã¯ã©ã®ãããæéãããããŸããïŒ
AïŒVSLã¯ãæåã®é±å
ã®æ©æç·©åããã³6ã¶æã®æ²»çåŸã®å®å
šã§æ°žç¶çãªé¢ç¯åŸ©å
ã䞻匵ããŠããŸãã蚌èšã¯12æ¥ä»¥å
ã®çã¿è»œæžã説æããŠããŸãããããã®ã¿ã€ã ã©ã€ã³ã¯å
·äœçã§åçã§ããã³ã©ãŒã²ã³ããŒã¹ã®ãµããªã¡ã³ãã®ã㢠ã¬ãã¥ãŒããã蚌æ ã¯ãäžè¬çã«ããé·ãæéã«ããã£ãŠããæ§ãããªå¹æã瀺åããŠãããåå¥ã®çµæã¯å€§ããç°ãªããŸãã
QïŒåºèãŸã㯠Amazon ã§ RejuvaJoint ãå
¥æã§ããŸããïŒ
AïŒVSLã«ããã°ã補åã¯å
¬åŒãŠã§ããµã€ãã§ã®ã¿è²©å£²ãããAmazonãeBayãWalmartããŸãã¯å°å£²è¬å±ã§ã¯å©çšã§ããŸããããã®æä»æ§ã¯çŽæ¥å¯Ÿå¿ãµããªã¡ã³ã ããŒã±ãã£ã³ã°ã®äžè¬çãªæ©èœã§ããã補åã®äž»åŒµãšè¿åããªã·ãŒãè©äŸ¡ããéã«æ³šç®ãã䟡å€ããããŸãã
æåŸã«
Arthrocel / RejuvaJoint VSLã¯ãããŒã±ãã£ã³ã°å·¥äœã®äžéšãšããŠãæ¬åœã«éæãããŠããŸããã»ã¬ããªãã£æš©éãæ©é¢åãææ çãªç©èªãé°è¬ãã¬ãŒãã³ã°ãèšåºçã«èãããçµ±èšãããã³å€æ®µéäŸ¡æ Œã¢ã³ã«ãŒããã¬ãå¥åº·ããã°ã©ã ã®ããžã¥ã¢ã«ã°ã©ããŒã§å®è¡ãããåäžã®é£ç¶ãããªå ã«å±éããŸãã説åŸã¢ãŒããã¯ãã£ã¯ã©ã³ãã ã§ã¯ãããŸããããåèŠçŽ ãæ¬¡ã®ããã«èŠèŽè ãæºåããããã®æ£ç¢ºãªã·ãŒã±ã³ã¹è«çã«åŸããèŠèŽè ãäŸ¡æ Œãæããããç¬éã«å°éããŠãããšãã«ããŒã¯åãã环ç©çãªå¿ççå¢ããæ§ç¯ããŸããçŽæ¥å¯Ÿå¿ã³ããŒã©ã€ãã£ã³ã°ã®åŠçã«ãšã£ãŠãããã¯é«æçæ§ãé«çã¿ã®ãªãŒãã£ãšã³ã¹ã®ããã®é·åœ¢VSLãæ§é åããæ¹æ³ã«ã€ããŠã®æçšãªã±ãŒã¹ã¹ã¿ãã£ã§ãã
補åã®äž»åŒµãšããŠãããããVSLã¯æ éãªè³Œå ¥è ãèªèãã¹ãé倧ãªåŒ±ç¹ãæã£ãŠããŸããäž»èŠãªã¡ã«ããºã ããã¹ãŠã®é¢ç¯çã®å¯äžã®åå ãšããŠã®ã³ã©ãŒã²ã³äžè¶³ãã¯ãé¢ç¯çŸæ£ã®çŸåšã®ç§åŠççè§£ãåæ ããªãé床ãªåçŽåã§ããåŒçšãããèšåºèšŒæ ïŒ1,571人詊éšãããŒããŒããšã¹ã¿ã³ãã©ãŒãããã®æ©é¢çèªèïŒã¯ãå ¬éç ç©¶ããŒã¿ããŒã¹ãéããŠæ€èšŒããããšã¯ã§ããŸãããã»ã¬ããªãã£ææºãæ¬ç©ã®æ¿èªãšããŠç¢ºèªããããšã¯ã§ããŸããããããŠæåé瀺ã¯äžå®å šã§ãããããã¯ç¬ç«ããå®å šæ§è©äŸ¡ãšç«¶äºçè©äŸ¡ã®äž¡æ¹ãå¶éããŠããŸãããããã®ãããããããµããªã¡ã³ãã«äŸ¡å€ããªãããšãå¿ ãããæå³ããŸããããã®äžéšã®æåã¯æ»èªæžã¿æç®ã§èª¬åŸåã®ããã¡ã«ããºã ãæã£ãŠããŸããããããVSLã䞻匵ããããšãšèšŒæ ããµããŒãããŠããããšã®éã®ã®ã£ããã¯å®è³ªçã§ãã
ç©æ¥µçã«ãã®è£œåãç ç©¶ããŠããèªè ã«ãšã£ãŠããããã¿ãŒã²ããã«ããŠããåºæ¬çãªç¶æ ã¯æ¬ç©ã§ãããããã話ãèŠãã¿ã¯æ¬ç©ã§ãããåŸæ¥ã®é¢ç¯çæ²»çã®éçã¯æ¬ç©ã§ãããããã®äºå®ã¯ãåãæã£ãŠããããçéžããããã«ããŸãããããã50äžå¹Žä»¥äžã®ã¢ã¡ãªã«äººã«åœ±é¿ãäžããæ°å幎éå»åŠçãœãªã¥ãŒã·ã§ã³ã«èããç¶æ ãæ°žç¶çãã€èªç¶ã«è§£æ±ºãããšäž»åŒµãã補åã¯ãåºçæžã¿ãã¢ã¬ãã¥ãŒç ç©¶ãFDA泚èŠãåºç¯ãªå»åŠæ¡çšã®å¯Ÿè±¡ã«ãªãã§ãããã10åã®ã«ãŠã³ãããŠã³ã¿ã€ããŒãšæä»çãªãŠã§ããµã€ãã§ã¯ãªãã䞻匵ã®ã¹ã±ãŒã«ã𿝿ãã蚌æ ã®éã®ãã®ã®ã£ããã¯ãå©çšå¯èœãªæãéèŠãªã·ã°ãã«ã§ãã
ãã®ç Žå£ã¯ Daily Intel Service ã®äžéšã§ãããVSL ããã³åºåã³ããŒåæã®ç¶ç¶äžã©ã€ãã©ãªã§ããé¢ç¯å¥åº·ãé¢ç¯çããŸãã¯ãŠã§ã«ãã¹ãµããªã¡ã³ã空éã®åæ§ã®è£œåãç ç©¶ããŠããå Žåã¯ãèªã¿ç¶ããŠãã ããããã®èšäºã«è¡šç€ºããããã¿ãŒã³ã¯ãã«ããŽãªå šäœã§ãã®æ¹æ³ã§åçºããè³Œå ¥æ±ºå®ãããåã«çè§£ãã䟡å€ããããŸãã
å 責äºé ïŒãã®èšäºã¯ç ç©¶ããã³æè²ç®çã®ã¿ã§ããå»åŠãæ³åŸããŸãã¯è²¡åçãªã¢ããã€ã¹ã§ã¯ãªãã補åãŸãã¯ãã®è£œé è ãšææºããŠããŸãããå¥åº·ãŸãã¯è²¡åäžã®æ±ºå®ãè¡ãåã«ãåžžã«èªå®ããããããã§ãã·ã§ãã«ã«çžè«ããŠãã ããã
Comments(0)
No comments yet. Members, start the conversation below.
Related reads
- DISreviews
GumAktivã¬ãã¥ãŒãšåºååæïŒãªãµãŒããã¡ãŒã¹ãã®èå¯
GumAktivãããªã»ãŒã«ã¹ã¬ã¿ãŒïŒVSLïŒã®åé æ°ç§éã¯ãã¹ã¯ããŒã«äžã®ãã¥ãŒã¢ãŒãéã¥ãã«ããããã«èšèšããã質åãå±éããŸãïŒããããã®éããã¯ããªã¢ã¯ãæ¯ç§ã€ã³ãã©ã³ããããéããããè¿ éã«ããªãã®æ¯ã修埩ã§ããã§ããããïŒããšãããã¬ãŒãº...
Read - DISreviews
BurnSlim VSL ãšåºååæ
BurnSlim ã®ãããªã»ãŒã«ã¹ã¬ã¿ãŒã®åé æ°ç§ã®ã©ããã§ãç¹å®ã®ä¿®èŸçãªè³ãã眮ãããŠããŸããèŠèŽè ã¯ãã±ãªãŒã»ã¯ã©ãŒã¯ãœã³ãæ¯æãŒã©ãã³ã®ç«æ¹äœã 1 ã€é£ã¹ãããšã§ 68 æ¥éã§ 60 ãã³ãäœéãæžããããšèšãããŠããŸãâŠ
Read - DISreviews
BurnFlow ã¬ãã¥ãŒãš VSL åæ
BurnFlow ãããªã»ãŒã«ã¹ã¬ã¿ãŒã®ãªãŒããã³ã° 30 ç§ã¯ã補åããå§ãŸããŸãããã»ã¬ããªãã£ã®åçœããå§ãŸããŸãããã¬ãŒã³ã¿ãŒã¯ã女åªã¬ãã«ã»ãŠã£ã«ãœã³ãšã®ãã¬ã¹ã€ã³ã¿ãã¥ãŒãšããŠãã¬ãŒãã³ã°ããããã®ããé³èªããŸãããã®äžã§ãåœŒå¥³ã¯æ¯æãŒã©ãã³ãã¥ãŒããé£ã¹ãããšã§ 2 ã¶æã§ 77 ãã³ãäœéãèœãšããããšã«ã€ããŠèª¬æããŠããŸããããžã ãªããæ°çããã¿ããã€ãšãããªããããŒãããã¢ã€ã¹ã¯ãªãŒã ããã¶ã諊ããã«ããšã®ããšã§ãâŠ
Read